Is Back Pain a Side Effect of Mounjaro?

You've noticed back pain since starting Mounjaro, here's how to think about it

It's unsettling to develop a new symptom once you've started a medicine, even when the two things may have nothing to do with each other. If you've searched this question, you're probably trying to work out whether to be worried, whether to tell someone, and whether to carry on. All of those are sensible instincts.

Back pain is extraordinarily common in the general population, so coincidence is genuinely likely. The NHS tirzepatide medicines page and the Mounjaro SmPC list the most frequent side effects as nausea, diarrhoea, vomiting, constipation, reduced appetite and injection-site reactions. Back pain does not feature among the common (affecting more than 1 in 100 people) or very common (more than 1 in 10) reactions. Some musculoskeletal events were recorded at low frequency in trials, but the signal is weak and the absolute rates were small.

What can happen, practically speaking: people on tirzepatide often reduce their activity as their body adjusts to the medicine in the first weeks, particularly if nausea is making exercise uncomfortable. Spending more time sitting, or changing your movement habits, is one of the more plausible reasons for back discomfort to appear around the same time as starting treatment. Rapid changes in body weight (especially in the early months) can also shift how load is distributed across the spine and hips. Neither mechanism is cause for alarm, but both are worth mentioning to your prescriber. For a broader overview of Mounjaro side effects, the picture is dominated by gastrointestinal effects, which tells you something about where the medicine acts.

The symptom that does need urgent attention: back pain as a warning sign

There is one scenario where back pain alongside Mounjaro requires you to stop reading and call 999 or go to A&E: severe, persistent pain in the upper or mid-abdomen that radiates through to the back, particularly if accompanied by nausea, vomiting, or feeling very unwell.

This symptom pattern is a classic presentation of acute pancreatitis. In January 2026 the MHRA issued a Drug Safety Update specifically about GLP-1 receptor agonists (the class of medicines that includes tirzepatide) highlighting acute pancreatitis as a known but infrequent serious risk. The update reinforced the importance of patients recognising this symptom and seeking same-day medical help rather than waiting. You can read the MHRA Drug Safety Update index for the full communication.

To be clear: the vast majority of people who notice back discomfort on Mounjaro are not experiencing pancreatitis. Ordinary back pain (the kind that comes and goes, that you can pin to a chair or a bad night's sleep) does not carry this warning. The distinction that matters is severity and persistence of abdominal pain spreading to the back, not incidental musculoskeletal ache. If you're unsure which you're dealing with, that uncertainty is itself a reason to contact a clinician the same day. Our prescribers discuss this kind of nuance as part of ongoing aftercare; you can also reach the team through our contact page if you're an existing patient.

Other gastrointestinal side effects worth knowing alongside this one

Because Mounjaro slows gastric emptying and acts on gut hormone receptors, most of its side effects originate in the digestive system. Stomach pain is a more commonly reported complaint than back pain, and it usually peaks in the days after a dose increase before easing. Diarrhoea and excess burping follow a similar pattern, uncomfortable, but generally manageable and settling over time. If nausea is a problem, there are strategies that can help; the question of whether anti-nausea medicines like ondansetron are appropriate is one our prescribers can discuss.

Less common reports from trial participants included hair shedding, which tends to be temporary and related to rapid weight change rather than the medicine directly. The broader picture of what Mounjaro can and cannot cause is covered in detail on our full side-effect guide. Every listed side effect comes from real trial data, not anecdote, and the Mounjaro SmPC on the eMC remains the definitive reference for the complete, up-to-date list.

If you're considering starting treatment and want to understand your individual risk profile properly, starting a free consultation with our prescribers is the right first step. Suitability is assessed individually, and side-effect questions are a central part of that conversation, not an afterthought.